Bedrocan cannabis now available in Australia

Used by patients in the Netherlands since 2003, Bedrocan® standardised cannabis is now available for patients in Australia. This includes the same cannabis used in the NSW palliative care clinical trial.

Product profile

Administered by vaporization, the consistent chemical profile of the cannabis better allows doctors to monitor dosage, condition progress, and reduce the risk of overdosing and unwanted side effects.

Being free of microbial contaminants (molds, fungi, and bacteria), pesticides, and heavy metals, Bedrocan® cannabis is safe for vaporization and inhalation into the lungs. These qualities are especially important for people with weakened immune systems.

The published Clinical primer provides information to assist health professionals on dosing, safety, and side effects.

Australian distributor

Novachem, a specialist import and distribution agent, supplies cannabis and vaporization technology to licensed pharmacies in Australia.